Ken Griffin Harvard Bioscience Inc Put Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$2.64 - $3.54 $2,376 - $3,186	900 Added 75.0%	2,100 $5,000
Q2 2024 Aug 14, 2024	SELL	$2.77 - $4.63 $2,770 - $4,630	-1,000 Reduced 45.45%	1,200 $3,000
Q1 2024 May 15, 2024	BUY	$4.02 - $5.39 $8,843 - $11,858	2,200 New	2,200 $9,000
Q3 2023 Nov 14, 2023	BUY	$4.0 - $5.82 $4,800 - $6,984	1,200 Added 600.0%	1,400 $6,000
Q2 2023 Aug 14, 2023	SELL	$4.19 - $6.16 $838 - $1,232	-200 Reduced 50.0%	200 $1,000
Q1 2023 May 15, 2023	BUY	$2.45 - $4.22 $980 - $1,688	400 New	400 $1,000

31.5M

700

2.1K

Ticker HBIO
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 41,636,500
Market Cap $90.4M
Description
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.